Elite Mouse Monoclonal Antibody Discovery Service

Background Workflow Advantage Application Related Services FAQ Online Inquiry

For over two decades, Creative Biolabs has stood at the forefront of antibody engineering and discovery. We specialize in providing high-affinity, publication-ready Mouse Monoclonal Antibody (mAb) candidates for a spectrum of research applications. While the classic hybridoma technique remains a cornerstone of immunology, the demands for higher throughput, greater epitope diversity, and rapid development timelines have driven the adoption of superior technologies. Creative Biolabs proudly offers an advanced Mouse Monoclonal Antibody Discovery service, leveraging our cutting-edge phage display platform. By constructing and screening immune antibody library via phage display, we bypass the limitations of traditional methods to deliver mouse antibodies of exceptional quality and specificity.

Discuss Your Project Today

The Power of Phage Display-Based Mouse Monoclonal Antibody Discovery

The mouse remains the most widely used host for antibody generation due to its robust immune response and well-characterized genetics. However, traditional hybridoma fusion is often a bottleneck—it is time-consuming, labor-intensive, and frequently biased toward immunodominant epitopes, causing researchers to miss critical functional antibodies.

Our phage display-based Mouse Monoclonal Antibody discovery platform revolutionizes this process. Instead of relying on the random fusion of B-cells with myeloma cells, we capture the entire activated B-cell repertoire of an immunized mouse and display it on the surface of bacteriophages. This creates a highly complex immune antibody library that serves as a permanent, high-fidelity resource for panning against any target.

This "immune-first" approach combines the power of in vivo affinity maturation within the mouse with the unparalleled screening efficiency of in vitro phage display.

Our Workflow: Constructing and Screening Immune Antibody Library via Phage Display

At Creative Biolabs, our Mouse Monoclonal Antibody Discovery service is a comprehensive, milestone-driven process managed by PhD-level scientists.

Step 1: Strategic Immunization

Success begins with a robust immune response. Our team possesses deep expertise in designing immunization strategies tailored to your specific antigen. We don't rely on a one-size-fits-all protocol.

Antigen Types: Recombinant proteins, peptides (with proprietary carrier conjugation), whole cells, DNA immunization, and VLP (Virus-Like Particles).
Adjuvants: We employ a panel of adjuvants and optimized immunization schedules to maximize B-cell activation and class-switching.
Host: We utilize various mouse strains to ensure the strongest possible response to your target.

Step 2: B-Cell Repertoire Isolation

Following confirmation of a high antibody titer in the mouse serum, we harvest the spleen and/or lymph nodes. Total RNA is extracted from the B-lymphocyte population, capturing the complete genetic snapshot of the in vivo matured antibody repertoire.

Step 3: Immune Antibody Library Construction

Gene Amplification: Using RT-PCR with a highly optimized set of mouse-specific primers, we amplify the variable heavy (VH) and light (VL) chain gene repertoires.
Library Cloning: The VH and VL genes are randomly linked to create single-chain Fv (scFv) or Fab fragments. These fragments are then cloned into our proprietary phagemid vectors, which are designed to fuse the antibody fragment to the phage coat protein (pIII).
Library Generation: The phagemid library is transformed into E. coli, which are subsequently infected with helper phages. This "packs" the antibody gene inside the phage particle while "displaying" the corresponding antibody protein on its outside.

Our platforms routinely generate immune antibody library complexities exceeding 10^8 - 10^11 unique clones, ensuring comprehensive coverage of the immune response.

Fig. 1 Immune mouse antibody library construction. (Creative Biolabs Authorized). Fig. 1 Mouse Immunized Phage Display Library.

Step 4: High-Throughput Biopanning and Screening

With the library in hand, we perform iterative rounds of "biopanning" to isolate phages that display high-affinity binders to your target. This is where our technical expertise truly differentiates us. We do not just use simple plastic-immobilized panning.

Our advanced screening strategies include:

Solid-Phase Panning: Against a purified, plate-bound antigen.
Solution-Phase Panning: Capturing antigen-antibody complexes in solution with streptavidin-biotin systems. This is ideal for preserving native protein conformation and selecting for the highest-affinity binders.
Cell-Based Panning: Screening directly against antigens expressed in their native context on the surface of live cells (overexpressing or endogenous).
Negative/Subtraction Panning: Eliminating binders to unwanted targets (e.g., other family members, parental cell lines, or tags) to ensure absolute specificity.
Epitope-Specific Panning: Using blocking antibodies or antigen fragments to isolate binders to a specific, desired functional domain.

Step 5: Hit Validation and Characterization

After 3-5 rounds of panning, enriched clones are screened by high-throughput phage ELISA or flow cytometry. Positive hits are sequenced to identify unique antibody families.

Advantages of Our Phage Display Immune Library Platform

When compared to traditional hybridoma or naïve library screening, our immune antibody library for Mouse Monoclonal Antibody discovery offers distinct, critical advantages:

Superior Affinity: Libraries are built from immunized animals, meaning the B-cells have already undergone somatic hypermutation and affinity maturation in vivo. This results in the direct isolation of mAbs with affinities in the nanomolar (nM) to picomolar (pM) range.
Unmatched Epitope Diversity: We rescue the genetic information (VH and VL) from all responding B-cells, not just those that fuse successfully. This allows for the discovery of antibodies against complex, conformational, or rare epitopes that are often missed by hybridoma.
Speed and Efficiency: The construction and screening of immune antibody library is significantly faster than the hybridoma workflow. We can proceed from immunization to validated, sequence-defined antibody fragments (scFv or Fab) in weeks, not months.
Format Flexibility: The primary output is a genetic sequence (scFv or Fab). This is an ideal starting point for downstream engineering. The antibody can be instantly reformatted into a full-length mouse IgG, a chimeric antibody, or a bispecific construct without the need for hybridoma sequencing and subcloning.
Target Versatility: Our platform excels with difficult targets, including toxins, highly homologous proteins, or non-immunogenic small molecules, where hybridoma development often fails.

Applications of Phage Display-Derived Mouse mAbs

The Mouse Monoclonal Antibody candidates discovered through our platform are robust and versatile, suitable for all standard research applications.

Diagnostic Research: Development of high-sensitivity reagents for ELISA, lateral flow, and IHC.
Structural Biology: Isolating antibodies that bind specific conformations for X-ray crystallography or Cryo-EM.
Functional Assays: Discovering neutralizing or activating antibodies for in vitro and in vivo (mouse model) studies.
Flow Cytometry: Generation of highly specific mAbs for complex multi-color panel analysis.
Therapeutic Surrogates: Serving as surrogate molecules for preclinical studies in mouse disease models before advancing to a humanized version.

Explore Our Comprehensive Services

While our phage display immune antibody library platform is a powerful engine, we offer a comprehensive suite of discovery technologies to ensure we always use the right tool for the job. Our Monoclonal Antibody Generation from Various Immunized Antibody Libraries Services:

Partner with the experts. Leverage the speed, power, and diversity of Creative Biolabs' advanced phage display platform to discover the high-affinity mouse monoclonal antibodies your research demands.

Contact Us Today for a Free Quote!

Frequently Asked Questions (FAQs)

Q: What is the main difference between an immune antibody library and a naïve library?

A: An immune antibody library is constructed from B-cells of an animal (like a mouse) that has been intentionally immunized with your specific antigen. The antibodies in this library have already undergone in vivo affinity maturation, resulting in high-affinity binders. A naïve library is built from a non-immunized host and represents the entire baseline antibody repertoire; it is much larger and more complex, and the initial hits usually have lower affinity, requiring in vitro maturation. For most projects, an immune library is faster and yields higher-affinity candidates.

Q: What affinity can I expect from this Mouse Monoclonal Antibody Discovery service?

A: Because our phage display platform starts with an immunized host, we routinely isolate antibodies with high affinity, typically in the single-digit nanomolar (nM) to high-picomolar (pM) KD range. This is often superior to the affinities of primary hits from hybridoma screening.

Q: What if my antigen is toxic or highly conserved (non-immunogenic)?

A: This is a key strength of our platform. For toxic antigens, we can use very short immunization protocols or DNA immunization to elicit a B-cell response without harming the animal. For highly conserved (homologous) proteins, the sensitivity of phage display screening allows us to identify rare antibody clones even from a weak immune response, which hybridoma fusion would almost certainly miss.

Q: Can you discover antibodies against a specific epitope?

A: Yes. Our biopanning strategies are highly customizable. We can perform "epitope-directed" screening by panning against specific peptide fragments of your protein or by using blocking antibodies to "mask" unwanted regions, thereby enriching for clones that bind only to your desired functional site.

Reference

Sun, Chunli, et al. "Flow Cytometry-Based Rapid Assay for Antigen Specific Antibody Relative Affinity in SRBC-Immunized Mouse Models." International Journal of Molecular Sciences 26.8 (2025): 3664. https://doi.org/10.3390/ijms26083664

×

Online Inquiry

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.